
Cancer is a frequent finding in patients with zzso and zzso is much more prevalent in patients with cancer, with important clinical zzso zzso is the second most common cause of death in cancer zzso zzso zzso zzso in cancer is also associated with a high rate of zzso zzso a requirement for long-term zzso and worsened quality of zzso zzso factors for zzso zzso include particular cancer types, chemotherapy (with or without zzso zzso the use of zzso agents, the presence of central zzso zzso and zzso Novel risk factors include zzso and zzso counts and tissue zzso A risk model for identifying cancer patients at highest risk for zzso has recently been zzso zzso therapy is safe and zzso for prophylaxis and treatment of zzso in patients with zzso Available zzso include zzso zzso and zzso weight zzso zzso zzso represent the preferred therapeutic option for zzso prophylaxis and zzso Their use may be associated with improved survival in cancer, although this issue requires further zzso Despite the significant burden imposed by zzso and the availability of effective zzso therapies, many zzso patients do not receive appropriate zzso prophylaxis as recommended by practice zzso zzso adherence to guidelines could substantially reduce zzso decrease resource use, enhance quality of life, and improve survival in these zzso 

